---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-283935"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:05:17.032759+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics gets Nasdaq extension until May 11, 2026 to regain $1 bid price

## Summary
- Received 180-day extension to May 11, 2026 from Nasdaq to meet $1.00 minimum bid price rule.
- No immediate effect on listing; stock continues trading on Nasdaq under PSTV.
- If bid price closes at $1.00+ for 10 consecutive days, compliance confirmed and matter closed.
- Company may implement reverse stock split if needed; no guarantee of regaining compliance.

## SEC filing metadata
- accession: 0001193125-25-283935
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312525283935/0001193125-25-283935-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312525283935/d55484d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-283935
- JSON: https://secwatch.observer/filing/0001193125-25-283935.json
- Plain text: https://secwatch.observer/filing/0001193125-25-283935.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.